Position in NRXP
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$167,284
+$145,925 QoQ
Shares Held
40,901
+307.9% QoQ
Ownership
0.094%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#21
of 47 holders
Holding Since
Dec 2020
23 quarters on record
Voting authority
Sole 13%
Shared 0%
None 87%
Common Shares in NRXP Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026MORGAN STANLEY holds $16,717,846,799 across 523 Biotechnology names. NRXP ranks #332 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | RPRX |
Royalty Pharma plc
|
42,931,597 | $2,407,174,637 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
3,242,139 | $1,610,467,694 | |
| 3 | ROIV |
Roivant Sciences Ltd.
|
42,592,905 | $1,507,362,901 | |
| 4 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,397,712 | $871,529,332 | |
| 5 | MRNA |
Moderna, Inc.
|
9,538,094 | $667,952,718 | |
| 6 | ARGX |
Argenx SE
|
643,123 | $596,670,219 | |
| 7 | TECH |
BIO-TECHNE Corp
|
6,374,717 | $450,373,747 | |
| 8 | INCY |
Incyte Corp
|
2,948,364 | $334,226,536 |
All Filings in NRXP
Export CSV
23 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $167,284 | 40,901 | Shares | Defined | 2026-08-13 | |
| 2026-03-31 | $21,359 | 10,028 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $27,178 | 10,029 | Shares | Defined | 2026-05-27 | |
| 2025-09-30 | $36,563 | 11,080 | Shares | Defined | 2026-05-27 | |
| 2025-06-30 | $14,330 | 4,396 | Shares | Defined | 2025-08-15 | |
| 2025-03-31 | $24,386 | 11,896 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $9,671 | 4,396 | Shares | Defined | 2025-05-15 | |
| 2024-09-30 | $7,429 | 4,396 | Shares | Defined | 2025-05-14 | |
| 2024-06-30 | $10,726 | 4,396 | Shares | Defined | 2025-05-14 | |
| 2024-03-31 | $20,743 | 43,948 | Shares | Defined | 2024-10-17 | |
| 2023-12-31 | $20,393 | 44,334 | Shares | Defined | 2024-08-16 | |
| 2023-09-30 | $12,304 | 47,326 | Shares | Defined | 2023-11-15 | |
| 2023-06-30 | $22,905 | 47,326 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $31,187 | 47,326 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $55,873 | 50,338 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $43,890 | 59,313 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $33,818 | 56,365 | Shares | Defined | 2022-10-27 | |
| 2022-03-31 | $126,902 | 51,797 | Shares | Defined | 2022-10-27 | |
| 2021-12-31 | $274,101 | 57,344 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $380,551 | 41,052 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $463,277 | 39,869 | Shares | Defined | 2021-08-23 | |
| 2021-03-31 BRPA | — | 670 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 BRPA | — | 1,359 | Shares | Defined | 2021-02-16 | |
| No filing history on record for this holder in this stock. | ||||||